Skip to main content

Market Overview

BridgeBio Pharma, Inc. (BBIO)

55.51 +0.39 (0.71%)

Analyst Ratings

DateResearch FirmActionCurrentPT
3/23/21SVB LeerinkMaintainsOutperform75.0
3/04/21MizuhoMaintainsBuy86.0
2/09/21Goldman SachsReinstatesBuy83.0
1/11/21HC Wainwright & Co.MaintainsBuy87.0
12/10/20HC Wainwright & Co.MaintainsBuy64.0
12/04/20SVB LeerinkMaintainsOutperform44.0
10/12/20HC Wainwright & Co.MaintainsBuy53.0
6/25/20B of A SecuritiesInitiates Coverage OnNeutral38.0
5/19/20BTIGInitiates Coverage OnBuy49.0
5/14/20SVB LeerinkReiteratesOutperform39.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter